Alzheimer disease: BACE1 inhibitor reduces β-amyloid production in humans

被引：0
|
作者：
Crunkhorn S.
机构：
来源：
Nature Reviews Drug Discovery | 2017年 / 16卷 / 1期
关键词：
D O I：
10.1038/nrd.2016.271
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：18 / 18
相关论文
共 50 条
  • [1] BACE1 inhibitor reduces β-amyloid production in humans
    不详
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (01)
  • [2] The Selective BACE1 Inhibitor VIa Reduces Amyloid-β Production in Cell and Mouse Models of Alzheimer's Disease
    Cheng, Xiaorui
    Zhou, Yu
    Gu, Wei
    Wu, Jie
    Nie, Aihua
    Cheng, Junping
    Zhou, Jinwu
    Zhou, Wenxia
    Zhang, Yongxiang
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 37 (04) : 823 - 834
  • [3] The selective BACE1 inhibitor VIa reduces Aβ production in a mouse model of Alzheimer's disease
    Cheng, Xiao-rui
    Zhou, Yu
    Gu, Wei
    Nie, Ai-hua
    Cheng, Jun-ping
    Zhou, Wen-xia
    Zhang, Yong-xiang
    [J]. FASEB JOURNAL, 2014, 28 (01):
  • [4] Understanding BACE1:: essential protease for amyloid-β production in Alzheimer's disease
    Stockley, J. H.
    O'Neill, C.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) : 3265 - 3289
  • [5] Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease
    J. H. Stockley
    C. O’Neill
    [J]. Cellular and Molecular Life Sciences, 2008, 65 : 3265 - 3289
  • [6] The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
    Kennedy, Matthew E.
    Stamford, Andrew W.
    Chen, Xia
    Cox, Kathleen
    Cumming, Jared N.
    Dockendorf, Marissa F.
    Egan, Michael
    Ereshefsky, Larry
    Hodgson, Robert A.
    Hyde, Lynn A.
    Jhee, Stanford
    Kleijn, Huub J.
    Kuvelkar, Reshma
    Li, Wei
    Mattson, Britta A.
    Mei, Hong
    Palcza, John
    Scott, Jack D.
    Tanen, Michael
    Troyer, Matthew D.
    Tseng, Jack L.
    Stone, Julie A.
    Parker, Eric M.
    Forman, Mark S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (363)
  • [7] The selective BACE1 inhibitor VIa reduces Aβ production and ameliorates behavioral deficits in a mouse model of Alzheimer's disease
    Cheng, Xiao-rui
    Zhou, Yu
    Gu, Wei
    Nie, Ai-hua
    Cheng, Jun-ping
    Zhou, Jin-wu
    Zhou, Wen-xia
    Zhang, Yong-xiang
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 : 102 - 102
  • [8] Promotion of BACE1 mRNA alternative splicing reduces amyloid β-peptide production
    Mowrer, Karen R.
    Wolfe, Michael S.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (27) : 18694 - 18701
  • [9] BACE1 in Alzheimer's disease
    Sathya, M.
    Premkumar, P.
    Karthick, C.
    Moorthi, P.
    Jayachandran, K. S.
    Anusuyadevi, M.
    [J]. CLINICA CHIMICA ACTA, 2012, 414 : 171 - 178
  • [10] BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
    Robert Vassar
    [J]. Alzheimer's Research & Therapy, 6
12345